Analyst Research

Report Title Price
Provider: Reuters Investment Profile
$20.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: Wright Reports
$75.00
Provider: GlobalData
$125.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Bionomics Ltd Acquires Eclipse Therapeutics Inc


Sunday, 16 Sep 2012 07:10pm EDT 

Bionomics Ltd announced that it has acquired San Diego-based private biotechnology company Eclipse Therapeutics Inc (Eclipse) in a scrip-based USD 10 million deal. With consideration of approximately 23.9 million shares at AUD 0.4176 per share, Eclipse shareholders, that include NASDAQ-listed Biogen Idec, will own approximately 6.5% of Bionomics' issued capital. 

Company Quote

0.53
-0.0050 -0.93%
11 Jul 2014